Larch Arabinogalactan Polyphenol Composition for URTI Prophylaxis
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current prevention methods for upper respiratory tract infections (URTI), particularly those caused by rhinoviruses and common cold, are inadequate, with existing solutions like vaccinations having limitations and no effective means to reduce the risk of infection.
Innovation Solution
A composition comprising arabinogalactan and polyphenols from larch trees is used for prophylactic treatment, enhancing the adaptive immune response and administered daily to reduce the incidence of URTI, rhinovirus infections, and common cold in susceptible individuals.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If vaccinations are used for prevention, then immune protection is improved, but limitations and inefficacy against rhinovirus and common cold persist
Solution Approach 1:
The patent changes the preventive approach from vaccination (which targets specific pathogens) to immunomodulation using arabinogalactan and polyphenols, altering the immune system's functional parameters to provide broad-spectrum protection against multiple pathogens including rhinoviruses and common cold agents
2Ease of operation
If simple hand washing and hygiene measures are used, then basic prevention is maintained, but inadequate protection against URI occurs
Solution Approach 1:
The patent combines two complementary substances - arabinogalactan (a polysaccharide) and polyphenols (antioxidant compounds) - into a composite preparation that synergistically enhances immune function, providing more effective protection than single-substance approaches while remaining easy to administer
3Strength
If arabinogalactan extract is administered, then immune system stimulation occurs, but proven reduction in URI risk in real subjects is lacking
Solution Approach 1:
The patent introduces polyphenols as an intermediary substance that works synergistically with arabinogalactan, enhancing the overall immunomodulatory effect and demonstrating proven prophylactic efficacy in reducing URI risk in real subjects, addressing the limitation of arabinogalactan alone
Data Source
AI summary
The present invention discloses a composition comprising arabinogalactan and polyphenols from larch trees for the use in prophylactic treatment of upper respiratory tract infections.